Infimer (Israel) Performance
| INFR Stock | ILA 8,000 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of 43.72, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Infimer will likely underperform. At this point, Infimer has a negative expected return of -1.92%. Please make sure to check out Infimer's semi deviation, variance, jensen alpha, as well as the relationship between the downside deviation and information ratio , to decide if Infimer performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Infimer has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in May 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Total Cashflows From Investing Activities | 225 K |
Infimer |
Infimer Relative Risk vs. Return Landscape
If you would invest 3,000,000 in Infimer on January 5, 2025 and sell it today you would lose (2,200,000) from holding Infimer or give up 73.33% of portfolio value over 90 days. Infimer is generating negative expected returns and assumes 10.1384% volatility on return distribution over the 90 days horizon. Simply put, 90% of stocks are less volatile than Infimer, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Infimer Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Infimer's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Infimer, and traders can use it to determine the average amount a Infimer's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.189
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | INFR |
Estimated Market Risk
| 10.14 actual daily | 90 90% of assets are less volatile |
Expected Return
| -1.92 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.19 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Infimer is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Infimer by adding Infimer to a well-diversified portfolio.
Infimer Fundamentals Growth
Infimer Stock prices reflect investors' perceptions of the future prospects and financial health of Infimer, and Infimer fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Infimer Stock performance.
| Return On Asset | -0.33 | |||
| Operating Margin | (9.80) % | |||
| Current Valuation | 25.15 M | |||
| Shares Outstanding | 1.06 M | |||
| Price To Earning | (867.76) X | |||
| Price To Sales | 4,759 X | |||
| Revenue | 378 K | |||
| EBITDA | (3.15 M) | |||
| Cash And Equivalents | 14 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 289 K | |||
| Book Value Per Share | (5.82) X | |||
| Cash Flow From Operations | (1.59 M) | |||
| Earnings Per Share | (5.30) X | |||
About Infimer Performance
By analyzing Infimer's fundamental ratios, stakeholders can gain valuable insights into Infimer's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Infimer has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Infimer has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Infimer Ltd develops technology and production processes for converting municipal solid waste. The company was founded in 2013 and is based in Avihayil, Israel. INFIMER operates under Waste Management classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 23700 people.Things to note about Infimer performance evaluation
Checking the ongoing alerts about Infimer for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Infimer help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Infimer generated a negative expected return over the last 90 days | |
| Infimer has high historical volatility and very poor performance | |
| Infimer has accumulated 289 K in total debt. Infimer has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Infimer until it has trouble settling it off, either with new capital or with free cash flow. So, Infimer's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Infimer sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Infimer to invest in growth at high rates of return. When we think about Infimer's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 378 K. Net Loss for the year was (7.99 M) with loss before overhead, payroll, taxes, and interest of (899 K). | |
| Infimer has accumulated about 14 K in cash with (1.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 14.0% of the company shares are held by company insiders |
- Analyzing Infimer's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Infimer's stock is overvalued or undervalued compared to its peers.
- Examining Infimer's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Infimer's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Infimer's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Infimer's stock. These opinions can provide insight into Infimer's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Infimer Stock analysis
When running Infimer's price analysis, check to measure Infimer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infimer is operating at the current time. Most of Infimer's value examination focuses on studying past and present price action to predict the probability of Infimer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infimer's price. Additionally, you may evaluate how the addition of Infimer to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |